Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02264990
Title Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Subjects Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer Who Are Current or Former Smokers
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors AbbVie
Indications

lung non-small cell carcinoma

Therapies

Pemetrexed Disodium

Carboplatin

Paclitaxel

Veliparib

Cisplatin

Age Groups: adult
Covered Countries USA | ESP | DEU | CAN

Additional content available in CKB BOOST